Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
23.90
-0.01 (-0.04%)
Oct 30, 2024, 4:00 PM EDT

Chugai Pharmaceutical Company Description

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.

It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases.

Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan.

Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical logo
Country Japan
Founded 1925
Industry Drug Manufacturers - General
Sector Healthcare
Employees 7,604
CEO Osamu Okuda

Contact Details

Address:
2-1-1 Nihonbashi-Muromachi
Chuo, 103-8324
Japan
Phone 81 3 3281 6611
Website chugai-pharm.co.jp

Stock Details

Ticker Symbol CHGCY
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency JPY
ISIN Number US1712691039
SIC Code 2834

Key Executives

Name Position
Dr. Osamu Okuda President, Chief Executive Officer and Chairman
Iwaaki Taniguchi Executive Vice President, Head of Finance Supervisory Division, Chief Financial Officer and Director
Toshiya Sasai Executive of Investor Relations Group and Corporate Communications Department
Masayoshi Higuchi Vice President and Head of Quality, Regulatory Compliance Unit, Business Strategy and Compliance Dept.
Junichi Takano Head of Marketing and Sales Division
Shinji Hidaka Executive Vice President
Junichi Ebihara Executive Vice President
Dr. Yoshiaki Ohashi Senior Vice President and Full-time Audit Supervisory Board Member
Tetsuya Yamaguchi Executive Vice President and Head of PHC Solution Unit
Yoshiyuki Yano Executive Vice President